Perseon Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that the company received clearance from the U.S. FDA to market the MicroThermX® Microwave Ablation System for the specific indication of laparoscopic ablation procedures using image guidance.
New to our pages, Perseon Corporation, formerly BSD Medical Corporation, is a life sciences company that develops, manufactures, markets and services groundbreaking medical systems to treat cancer using heat therapy. Perseon’s MicroThermX® microwave ablation system employs precision-guided microwave energy to ablate soft tissue. The company says it has developed extensive intellectual property and distributes its products in the United States, Europe and Asia.
“This new indication increases the type of cases that our technology will be used for and the opportunity to expand the use of MicroThermX in surgical oncology,” said Clint Carnell, CEO of Perseon. “This moves us closer to achieving our clinical initiatives to benefit patients, physicians, and the healthcare system worldwide.”
Source: Globe Newswire